financetom
Market
financetom
/
Market
/
SEC official warns SPACs have “significant, undiscovered” issues
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SEC official warns SPACs have “significant, undiscovered” issues
Apr 8, 2021 6:11 AM

John Coates, a top official from the US Securities and Exchange Commission (SEC), has warned that the Special Purpose Acquisition Companies (SPACs) have some “significant and yet undiscovered” issues.

Share Market Live

NSE

SPAC listings bypass some safeguards that traditional IPOs offer which they make up for by offering big rewards.

These issues are not going to stop them by any means, said Coates, the director of the SEC’s Corporate Finance division. But, “They are relatively as yet incompletely worked through mechanisms, despite the fact they have been around for a while,” he said.

SPACs have raised nearly $100 billion YTD, with over 300 listed blank-check firms.

SPACs, or blank-check firms, are shell corporations designed to take companies public without taking the traditional IPO route. A listed SPAC targets and merges with a private firm, and takes it public.

Being recessive after the global financial crisis, SPACs became a red-hot investment asset in 2020. From celebrities to hedge funds, nearly 250 companies raised over $80 billion in the US in 2020. Several analysts had slated this precipitous surge in interest to speculation.

The rally cooled down in the beginning of March. The SPAC index has fallen over 20 percent from its February high. However, it could not escape the regulator’s eye.

Late in March, SEC commenced an inquiry into the SPAC frenzy. The regulator was seeking information on how underwriters manage the risks involved.

Coates said Wednesday that the agency is to issue more comments about the market in the coming weeks.

The regulator’s focus on SPACs is expected to increase now that the administration has changed. While Trump favoured all forms of public offerings, Democrats are expected to scrutinize deals closely.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial Stocks Steady Pre-Bell Wednesday
Sector Update: Financial Stocks Steady Pre-Bell Wednesday
Sep 4, 2024
09:15 AM EDT, 09/04/2024 (MT Newswires) -- Financial stocks were steady pre-bell Wednesday with the Financial Select Sector SPDR Fund ( XLF ) unchanged recently. The Direxion Daily Financial Bull 3X Shares ( FAS ) was down 0.2% and its bearish counterpart Direxion Daily Financial Bear 3X Shares ( FAZ ) was 0.1% lower. Blackstone (BX) said funds managed by...
Domestic Crude Oil Prices Down 0.9% MoM in June, EIA Reports
Domestic Crude Oil Prices Down 0.9% MoM in June, EIA Reports
Sep 4, 2024
05:55 AM EDT, 09/04/2024 (MT Newswires) -- Average domestic crude oil prices fell month-over-month in June by US$0.71, or 0.9%, to US$77.45 per barrel, the U.S. Energy Information Administration said in its Petroleum Marketing Monthly report released Tuesday. The average free-on-board cost of imported crude oil rose US$0.22, or 0.3% to US$72.11/b. The average landed cost of foreign crude decreased...
US STOCKS-Nasdaq slips, S&P 500 subdued after soft job openings report
US STOCKS-Nasdaq slips, S&P 500 subdued after soft job openings report
Sep 4, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Job openings stand at 7.67 mln in July * Nvidia ( NVDA ) drops after report of subpoena from US DoJ * Dollar Tree ( DLTR ) dives after cutting annual forecasts * Indexes: Dow up 0.23%, S&P 500...
Sector Update: Health Care Stocks Fall Premarket Wednesday
Sector Update: Health Care Stocks Fall Premarket Wednesday
Sep 4, 2024
09:16 AM EDT, 09/04/2024 (MT Newswires) -- Health care stocks fell in premarket hours Wednesday as The Health Care Select Sector SPDR Fund ( XLV ) declined by 0.4% and the iShares Biotechnology ETF ( IBB ) was down 0.7%. Athira Pharma ( ATHA ) shares were down more than 75% after the company said overnight that its phase 2/3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved